Profile

Nathaniel Turner

Location: USA

Nathaniel Turner is a Co-Owner of Goldin Auctions. He is a Co-Founder and serves as Chairman at Flatiron.

NUMBER

#36

Xs

812

Investments

151

Exits

52
Photo by areteindex.com
Unicorns
Overview
About Nathaniel Turner
Number of Portfolio Companies 15
Location USA

Nathaniel Turner is a Co-Owner of Goldin Auctions. He is a Co-Founder and serves as Chairman at Flatiron. He serves as Executive Chairman and Chief Executive Officer at Collectors Universe. Mr. Turner serves as Board Member at OneOncology. He is also an Angel Investor. He served as Board Member at Sema4. He also serves as Executive Chairman at Collectors Universe. Mr. Turner oversees all initiatives across provider solutions, clinical oncology, business development, sales operations, legal and other corporate functions. Before co-founding Flatiron Health, he was co-founder and CEO of Invite Media, an advertising technology company based in NYC. He also serves as a General Partner at Operator Partners. Invite Media was acquired by Google in 2010. Prior to Invite Media, Mr. Turner started numerous internet companies and also worked at Say Media and First Round Capital. An active angel investor, he has invested in over 30 technology startups throughout the country, including Bell Biosystems, Clover Health, Color Genomics, Doctor Evidence, Gravie, Notable Labs, Oscar and Quarter Health.

No data.

Company name
ENTRY ROUND
VALUATION at entry ($M)
Xs
VALUATION 
Plaid
Series A
$10M
1340
$13 400M
Blue Apron
Series A
$6M
316,67
$1 900M
Cityblock
Series A
$20M
315
$6 300M
Cityblock Health
Series A
$20M
285
$5 700M
BarkBox
$6,31M
253,57
$1 600M
Color
Series A
$32,7M
140,67
$4 600M
Clover Health
Series A
$55M
82,36
$4 530M
Flipkart
Series D
$700M
57,14
$40 000M
Cedar
Series B
$80M
40
$3 200M
Misfits Market
Series B
$178M
11,24
$2 000M
FullStory
Series C
$352M
5,17
$1 820M
Oscar
$1 365,08M
5,8
$7 920M
Epirus
Series B
$300M
4,5
$1 350M
Happy Money
Series D
$425M
2,71
$1 150M
HyperScience
Series D
$650M
2,54
$1 650M

No data.

2024